Compare FDMT & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FDMT | SRTA |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | 601 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.9M | 425.3M |
| IPO Year | 2019 | N/A |
| Metric | FDMT | SRTA |
|---|---|---|
| Price | $10.42 | $5.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $31.71 | $7.81 |
| AVG Volume (30 Days) | 646.0K | ★ 789.2K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $85,209,000.00 | N/A |
| Revenue This Year | N/A | $39.27 |
| Revenue Next Year | $70.28 | $8.52 |
| P/E Ratio | ★ N/A | $9.88 |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $3.03 | $3.85 |
| 52 Week High | $12.34 | $6.02 |
| Indicator | FDMT | SRTA |
|---|---|---|
| Relative Strength Index (RSI) | 57.81 | 63.18 |
| Support Level | $9.71 | $4.79 |
| Resistance Level | $10.70 | $5.99 |
| Average True Range (ATR) | 0.59 | 0.29 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 66.93 | 64.86 |
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.